KZA Ann: FDA AWARDS ORPHAN DESIGNATION TO PAXALISIB FOR ATRT - 17th Jun 2022, 9:17am

annb0t

annb0t

Top 20
KZA Ann: FDA AWARDS ORPHAN DESIGNATION TO PAXALISIB FOR ATRT
Price Sensitive: Y
Date: 17th Jun 2022, 9:17am

>>> Read announcement: Google: KZA Market Announcements
 
You must log in or register to reply here.

Similar threads

annb0t
KZA Ann: Paxalisib receives Fast Track Designation from US FDA - 7th Jul 2023, 9:16am
Replies
0
Views
74
annb0t
annb0t
annb0t
KZA Ann: FDA grants RPDD to paxaliaib for AT/RT - 6th Jul 2022, 5:57pm
Replies
0
Views
164
annb0t
annb0t
annb0t
KZA Ann: Proposed issue of securities - KZA - 31st Oct 2023, 1:18pm
Replies
0
Views
101
annb0t
annb0t
annb0t
KZA Ann: Kazia announces short term unsecured Promissory Note - 31st Oct 2023, 12:41pm
Replies
0
Views
87
annb0t
annb0t
annb0t
KZA Ann: Quarterly Activities/Appendix 4C Cash Flow Report - 31st Oct 2023, 9:52am
Replies
0
Views
65
annb0t
annb0t
Top Bottom